|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Net sales | |||
| Cost of goods sold | |||
| Gross profit | |||
| Selling, general and administrative expenses | |||
| Interest income | |||
| Interest expense | |||
| Foreign exchange (losses) gains — net | |||
| Other income — net | |||
| Income (loss) from affiliates | |||
| Income from continuing operations before income tax | |||
| Income tax expense | |||
| Income from continuing operations | |||
| Loss from discontinued operations, net of tax | |||
| Net income | |||
| Net income attributable to noncontrolling interests and redeemable noncontrolling interests | |||
| Net income attributable to Bunge shareholders (Note 23) | |||
| Convertible preference share dividends and other obligations | |||
| Earnings per share—basic (Note 23) | |||
| Net income from continuing operations (in dollars per share) | |||
| Net loss from discontinued operations (in dollars per share) | |||
| Net income attributable to Bunge shareholders—basic (in dollars per share) | |||
| Earnings per share—diluted (Note 23) | |||
| Net income from continuing operations (in dollars per share) | |||
| Net loss from discontinued operations (in dollars per share) | |||
| Net income attributable to Bunge shareholders —diluted (in dollars per share) |
Loading...
